Abstract
Background
Compared to non-Hispanic whites, African-American women tend to be diagnosed with breast cancer at an earlier age, to have less favorable tumor characteristics, and to have poorer outcomes from breast cancer. The extent to which differences in clinical characteristics account for the black/white disparity in breast cancer mortality is unclear. The purpose of this investigation was to examine the association of clinical, demographic, and treatment variables with total mortality and breast cancer recurrence by race/ethnicity in a cohort of women diagnosed with invasive breast cancer.
Methods
To this end, we used data on 3890 invasive breast cancer cases diagnosed at a single medical center. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI) for the association of tumor characteristics and treatment variables with mortality and recurrence.
Results
Compared to white women, black women with breast cancer presented with tumors that had worse prognostic factors, particularly higher stage, lower frequency of hormone-receptor positive tumors, and higher frequency of comorbidities. Hispanics also generally had less favorable prognostic factors compared to non-Hispanic whites. Among estrogen receptor-positive cases, blacks had roughly a two-fold increased risk of recurrence compared to non-Hispanic whites. However, ethnicity/race was not associated with total mortality. Tumor stage, tumor size, and Charlson comorbidity index were positively associated with mortality, and mammography and chemotherapy and hormone therapy were inversely associated with mortality.
Conclusion
In spite of poorer prognostic factors among blacks compared whites, race/ethnicity was not associated with total mortality in our study.
Similar content being viewed by others
References
DeSantis C, Fedewa SA, Sauer AG, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66:31–42.
Cunningham JE, Butler WM. Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis. Breast Cancer Res Treat. 2004;88:161–76.
Maskarinec G, Sen C, Koga K, Conroy SM. Ethnic differences in breast cancer survival: status and determinants. Women’s Health (Lond Engl). 2011;7(6):677–87. doi:10.2217/whe.11.67.
Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2):165–73.
Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MCU, Nielsen TO, Moorman PG, Earp HS, Millikan RC. Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA. 2006;295(21):2492–502.
Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in African-American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006;24(9):1342–9.
Keenan T, Moy B, Mroz EA, Ross K, Niemierko A, Rocco JW, Isakoff S, Ellisen LW, Bardia A. Comparison of the genomic landscape between primary breast cancer in African American versus white women and the association of racial difference with tumor recurrence. J Clin Oncol. 2015;33(31):3621–7.
Danforth DN. Disparities in breast cancer outcomes between Caucasians and African American women: a model for describing the relationship of biological and nonbiological factors. Breast Cancer Res. 2013;15:208.
Tao L, Gomez SL, Keegan THM, Kurian AW, Clarke CA. Breast cancer mortality in African-American and non-Hispanic white women by molecular subtype and stage at diagnosis: a population-based study. Cancer Epidemiol Biomark Prev. 2015;24(7):1039–45.
Breen N, Wesley MN, Merrill RM, et al. The relationship of socioeconomic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute black-white cancer survival study. Ethn Dis. 1999;9:111–25.
Samson ME, Porter NG, Hurley DM, Adams SA, Eberth JM. Disparities in breast cancer incidence, mortality, and quality of care among African American and European American women in South Carolina. South Med J. 2016;109(1):24–30. doi:10.14423/SMJ.
Gorin SS, Heck JE, Cheng B, Smith SJ. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Int Med. 2006;166:2244–52.
Vona-Davis L, Rose DP. The influence of socioeconomic disparities on breast cancer tumor biology and progrosis: a review. J Women’s Health. 2009;18(6):883–93.
Parise CA, Caggiano V. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California cancer registry, 2000-2010. BMC Cancer. 2013;13:449.
Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294(14):1765–72.
Kohler BA, Sherman RL, Howlander N, et al. Annual report to the nation on the status of cancer 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst. 2015;107(6):djv048.
Bellin E, Fletcher DD, Geberer N, Islam S, Srivastava N. Democratizing information creation from health care data for quality improvement, research, and education – the Montefiore medical center experience. Acad Med. 2010;85(8):1362–8. doi:10.1097/ACM.0b013e3181df0feb.
Roux AVD, Merkin SS, Arnett D, et al. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med. 2001;345:100.
Molto A, Dougados M. Comorbidity indices. Clin Exp Rheumatol. 2014;32(Suppl. 85):S131–4.
Sparano JA, Wang M, Zhao F, Stearns V, Martino S, Ligibel JA, Perez EA, Saphner T, Wolff AC, Sledge Jr GW, Wood WC, Davidson NE. Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial. J Natl Cancer Inst. 2012;104:406–14.
Curtis E, Quale C, Haggstrom D, Smith-Bindman R. Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics. Cancer. 2008;112(1):171–80.
Komenaka IK, Martinez ME, Pennington Jr RE, et al. Race and ethnicity and breast cancer outcomes in an underinsured population. J Natl Cancer Inst. 2010;102(15):1178–87.
Albain KS, Unger JM, Crowley JJ, Coltman CA, Hershman DL. Racial disparities in cancer survival among randomized clinical trial patients of the southwest oncology group. J Natl Cancer Inst. 2009;101:984–92.
Daly B, Olopade OI. Race, ethnicity, and the diagnosis of breast cancer (editorial). JAMA. 2015;313:141–2.
Menashe I, Anderson WF, Jatoi I, Rosenberg PS. Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst. 2009;101:993–1000.
DeSantis C, Jemal A, Ward E, Thun MJ. Temporal trends in breast cancer mortality by state and race. Cancer Causes Control. 2008;19:537–45.
Mandelblatt JS, Sheppard VB, Neugut AI. Black-white differences in breast cancer outcomes among older Medicare beneficiaries (editorial). JAMA. 2013;310(4):376–7.
Carmichael AR. Obesity and prognosis of breast cancer. Obes Rev. 2006;7(4):333–40.
Krishna A, Razak F, Lebel A, Smith GD, Subramanian SV. Trends in group inequalities and interindividual inequalities in BMI in the United States, 1993-2012. Am J Clin Nutr. 2015;101:598–605.
Lu Y, Ma H, Malone KE, Norman SA, Sullivan-Halley J, Strom BL, Marchbanks PA, Spirtas R, Burkman RT, Deapen D, Folger SG, Simon MS, Press MF, McDonald JA, Bernstein L. Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer. J Clin Oncol. 2011;29:3358–65.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure of Potential Conflicts of Interest
The authors declare that they have no competing interests.
Research Involving Human Participants
This study was approved the Institutional Review Board of the Albert Einstein College of Medicine. No animal subjects were included in this study.
Funding
This work was supported by institutional funds from the Albert Einstein College of Medicine.
Dr. Rohan receives support from the Breast Cancer Research Foundation.
We thank Dr. Chelsea Catsburg for her help in developing the breast cancer cohort.
Electronic supplementary material
ESM 1
(DOCX 21 kb)
Rights and permissions
About this article
Cite this article
Kabat, G.C., Ginsberg, M., Sparano, J.A. et al. Risk of Recurrence and Mortality in a Multi-Ethnic Breast Cancer Population. J. Racial and Ethnic Health Disparities 4, 1181–1188 (2017). https://doi.org/10.1007/s40615-016-0324-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40615-016-0324-y